IONOSOL Drug Patent Profile
✉ Email this page to a colleague
When do Ionosol patents expire, and when can generic versions of Ionosol launch?
Ionosol is a drug marketed by Hospira and Otsuka Icu Medcl and is included in three NDAs.
The generic ingredient in IONOSOL is dextrose; potassium chloride; potassium lactate; sodium chloride; sodium phosphate, monobasic anhydrous. There are nine drug master file entries for this compound. Additional details are available on the dextrose; potassium chloride; potassium lactate; sodium chloride; sodium phosphate, monobasic anhydrous profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for IONOSOL?
- What are the global sales for IONOSOL?
- What is Average Wholesale Price for IONOSOL?
Summary for IONOSOL
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 3 |
| DailyMed Link: | IONOSOL at DailyMed |

